Samsca Coupons & Discount Card - Compare Prices Near You

Here is essential safety and warning information regarding the use of tolvaptan (Samsca). Please read carefully and consult your healthcare provider with any concerns or questions.

• Hospital Initiation: Treatment should be started or restarted in a hospital setting for appropriate monitoring.

• Rapid Sodium Correction Risks: Tolvaptan (Samsca) is used to increase blood sodium levels. However, raising sodium levels too quickly can lead to osmotic demyelination syndrome (ODS), a potentially fatal condition. This risk is heightened for individuals with liver disease, poor nutrition, or alcohol use. Symptoms of ODS include difficulty speaking or swallowing, changes in mental state, weakness in limbs, or seizures.

• Liver Health Concerns: This medication can cause severe liver damage. Therefore, treatment is limited to 30 days with regular liver function monitoring. Signs of liver problems include yellowing of the skin or eyes, fatigue, nausea, low appetite, stomach discomfort, vomiting, and dark urine. If these occur, immediate medical attention is necessary, and discontinuation of the medication may be required.

• Dehydration Risks: Tolvaptan (Samsca) increases urination, risking dehydration. Ensure adequate fluid intake and monitor for signs like dry mouth, weight loss, rapid heart rate, or low blood pressure. Contact your healthcare provider if these symptoms appear.

• Drug Interactions: Many medications, including itraconazole and ritonavir, as well as grapefruit products, can interact with tolvaptan (Samsca). These interactions may increase drug levels in the body, causing side effects. Inform your provider of all medications you are taking and avoid starting new ones without consultation.

• Potassium Levels: This medication can elevate blood potassium levels, particularly if taken with other potassium-elevating drugs. Potassium levels will be monitored regularly.

• Urination Issues: If you have conditions affecting urination, such as benign prostatic hyperplasia or urinary blockages, inform your provider to prevent complications.

• Contraindications: Tolvaptan (Samsca) should not be used in individuals with autosomal dominant polycystic kidney disease outside FDA-approved settings, those unable to sense thirst, those with low blood sodium and volume, individuals taking certain interacting medications, or those unable to urinate.

In case of overdose or adverse reactions, seek emergency medical attention immediately. Always follow your healthcare provider's guidance when using this medication.

Taking this medication may lead to some common side effects, including feelings of thirst, a dry mouth, increased urination, and a lack of energy. Constipation and elevated blood sugar levels are also possible but are generally mild and manageable. While these effects are often not serious, it is important to consult a healthcare provider if they persist or worsen.

In some cases, users may experience additional side effects such as fever or a reduced appetite. While these are less common, they should be monitored, and any concerns should be discussed with a healthcare provider.

There are rare but serious side effects that require immediate medical attention. These include symptoms of osmotic demyelination syndrome, such as confusion and difficulty swallowing, as well as liver problems evidenced by yellowing skin or eyes and severe fatigue. Additionally, losing too much body fluid can lead to dehydration, characterized by a dry mouth, dizziness, and a rapid heart rate. High blood potassium levels are another serious concern, which can cause muscle weakness and irregular heartbeat. If any of these severe symptoms occur, urgent medical care is necessary.

Always remain vigilant about any changes in your health while on this medication and report unexplained symptoms to your healthcare provider.

Tolvaptan (Samsca) can interact with other medications, so it's important to inform your doctor and pharmacist about all drugs and supplements you are taking. This includes prescribed and over-the-counter medications, as well as vitamins and herbal supplements.

Certain medications should not be used with Tolvaptan, as interactions can occur that may require your doctor to adjust your treatment plan. These include azole antifungals like ketoconazole and itraconazole, HIV protease inhibitors such as lopinavir and ritonavir, and the antibiotic clarithromycin. Other drugs that affect how Tolvaptan is processed in your body include cobicistat, idelalisib, and some seizure medications like carbamazepine and phenytoin.

In some cases, your doctor might determine that using Tolvaptan with these medications is necessary, but they may adjust the dosage or frequency. Always consult your healthcare provider before making any changes to your medication regimen to ensure safety and efficacy.